Acer Therapeutics Inc. Quarterly Return On Assets in % from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Acer Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2023.
  • Acer Therapeutics Inc. Return On Assets for the quarter ending September 30, 2023 was -347 %, a 333% decline year-over-year.
  • Acer Therapeutics Inc. annual Return On Assets for 2022 was -129 %, a 220% decline from 2021.
  • Acer Therapeutics Inc. annual Return On Assets for 2021 was -40.1 %, a 73.3% increase from 2020.
  • Acer Therapeutics Inc. annual Return On Assets for 2020 was -150 %, a 54.3% decline from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -347 -267 -333% Jul 1, 2023 Sep 30, 2023
Q2 2023 -271 -207 -328% Apr 1, 2023 Jun 30, 2023
Q1 2023 -202 -146 -256% Jan 1, 2023 Mar 31, 2023
Q4 2022 -129 -88.4 -220% Oct 1, 2022 Dec 31, 2022
Q3 2022 -80.1 -27.8 -53.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -63.3 +6.07 +8.75% Apr 1, 2022 Jun 30, 2022
Q1 2022 -56.9 +44.2 +43.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -40.1 +110 +73.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -52.2 +76.5 +59.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -69.4 +39.1 +36% Apr 1, 2021 Jun 30, 2021
Q1 2021 -101 +9.03 +8.21% Jan 1, 2021 Mar 31, 2021
Q4 2020 -150 -52.9 -54.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -129 -41.4 -47.4% Jul 1, 2020 Sep 30, 2020
Q2 2020 -108 -38.4 -54.8% Apr 1, 2020 Jun 30, 2020
Q1 2020 -110 -48.3 -78.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -97.4 -38.2 -64.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 -87.3 -29.5 -50.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 -70 +13.3 +16% Apr 1, 2019 Jun 30, 2019
Q1 2019 -61.7 +30.2 +32.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 -59.2 +63.1 +51.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -57.9 +112 +65.9% Jul 1, 2018 Sep 30, 2018
Q2 2018 -83.4 +155 +65% Apr 1, 2018 Jun 30, 2018
Q1 2018 -91.9 +49.2 +34.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -122 -36 -41.7% Oct 1, 2017 Dec 31, 2017
Q3 2017 -170 -83.2 -96.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 -238 -161 -209% Apr 1, 2017 Jun 30, 2017
Q1 2017 -141 -72.1 -104% Jan 1, 2017 Mar 31, 2017
Q4 2016 -86.3 -9.27 -12% Oct 1, 2016 Dec 31, 2016
Q3 2016 -86.5 -4.23 -5.14% Jul 1, 2016 Sep 30, 2016
Q2 2016 -77.2 +14.6 +15.9% Apr 1, 2016 Jun 30, 2016
Q1 2016 -69 +33.1 +32.4% Jan 1, 2016 Mar 31, 2016
Q4 2015 -77.1 +10 +11.5% Oct 1, 2015 Dec 31, 2015
Q3 2015 -82.3 -8.31 -11.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 -91.8 -15.6 -20.5% Apr 1, 2015 Jun 30, 2015
Q1 2015 -102 -21.8 -27.2% Jan 1, 2015 Mar 31, 2015
Q4 2014 -87.1 +9.99 +10.3% Oct 1, 2014 Dec 31, 2014
Q3 2014 -74 +54.4 +42.4% Jul 1, 2014 Sep 30, 2014
Q2 2014 -76.2 +79.3 +51% Apr 1, 2014 Jun 30, 2014
Q1 2014 -80.3 +91.2 +53.2% Jan 1, 2014 Mar 31, 2014
Q4 2013 -97.1 +71.8 +42.5% Oct 1, 2013 Dec 31, 2013
Q3 2013 -128 +10.5 +7.59% Jul 1, 2013 Sep 30, 2013
Q2 2013 -155 -49 -46% Apr 1, 2013 Jun 30, 2013
Q1 2013 -172 -93.3 -119% Jan 1, 2013 Mar 31, 2013
Q4 2012 -169 Oct 1, 2012 Dec 31, 2012
Q3 2012 -139 Jul 1, 2012 Sep 30, 2012
Q2 2012 -106 Apr 1, 2012 Jun 30, 2012
Q1 2012 -78.2 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.